Transaction #11197 · Form 4 · 0002001162-25-000005
Century Therapeutics, Inc. · Purchase · Common Stock
Century Therapeutics, Inc. · Transacted November 19, 2025 · Filed November 20, 2025
What does this filing report?
An SEC Form 4 filing for Century Therapeutics, Inc. records a purchase involving Common Stock on November 19, 2025. The reported quantity was 35,000. The filing date is November 20, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Century Therapeutics, Inc.
- Company CIK
- 0001850119
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 35,000
- Reported price
- 0.4951 · See footnotes
- Reference value
- 17,328.5
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 3,271,453
- Ownership description
- Not reported
- SEC acceptance time
- Nov 20, 2025, 6:02 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Pfeiffenberger Brent ↗
President and CEO · Director
CIK 0002001162
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements.
- F2
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.488 to $0.5005. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.